← Leaderboards
Lawrence C Kuo
Mebias Discovery, Inc.
$5,983,188
Attributed
$14,321,663
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,321,663 · 3
By mechanism
UH3$7,453,877 · 1
UG3$6,867,786 · 2
Top collaborators
- James E. Barrett8 shared
- Sandra D. Comer1 shared
- Kevin B. Freeman1 shared
- Scott A. Reines1 shared
Most similar at Mebias Discovery, Inc.
Same institution · by research overlap
- James E. Barrett$4,805,544
- Scott A. Reines$1,177,644
Others in their field
Other Emerging Leaders on “Drug Discrimination”
- Giacomo Vacca · Kinetic River Corporation$5,486,916
- James E. Barrett · Mebias Discovery, Inc.$4,805,544
- Torri D Metz · University Of Utah$4,005,996
- Michael R Wilson · University Of California, San Francisco$3,454,166
- Camille C Cioffi · University Of Oregon$3,417,846
- Peter M Grace · University Of Tx Md Anderson Can Ctr$3,224,916
Research focus
Drug DiscriminationMediatingPreclinical StudyVentilatory DepressionResponseOpioid AgonistOpioidOpioid Use DisorderSedation ProcedureSelf AdministrationAnalgesicsApplications GrantsMu Opioid ReceptorsConstipationAdverse EffectsBeta-ArrestinClinical ResearchGtp-Binding ProteinsGenerationsG Protein-Coupled Receptor SignalingNovel TherapeuticsDrug DesignChronic PainDrug Candidate
Grant awards (9)
MEB-1170: A New Chemical Entity for the Treatment of Opioid Use Disorder$4,710,576
UG3 · FY2025 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$109,995
UH3 · FY2023 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,995,232
UH3 · FY2022 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$109,999
UH3 · FY2022 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$94,999
UH3 · FY2022 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,996,702
UH3 · FY2021 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$3,146,950
UH3 · FY2020 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,263,814
UG3 · FY2019 · DA · contact PI
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$893,396
UG3 · FY2018 · DA · contact PI